GlassScriptPhysician profile
Andrew Merrick Hall
NPI 1518272681
$1,740.82
in general payments reported to CMS, 2019-2025
27 companies · $253 in 2025
The $253 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $39.42 · 2021: $214 · 2022: $381 · 2023: $364 · 2024: $386 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,003.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $285.85 | 2021-2024 | Grafix, Oasis, Stravix |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $270.50 | 2019-2025 | Jublia, Cabtreo |
| Kowa Pharmaceuticals America, INC. | $102.74 | 2023 | Seglentis |
| Paratek Pharmaceuticals, INC. | $100.47 | 2021-2024 | Nuzyra |
| Kerecis Limited | $93.78 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Organogenesis INC. | $77.32 | 2024-2025 | Puraply Wound Matrix, Affinity |
| Abbvie INC. | $77.01 | 2022-2025 | |
| Depuy Synthes Sales INC. | $71.68 | 2023-2025 | Motoband |
| Nevro Corp. | $70.92 | 2022-2024 | Senza |
| Tenex Health INC. | $58.64 | 2021 | |
| Acumed LLC | $50.20 | 2025 | Acumed |
| Sandoz INC. | $49.55 | 2019 | |
| Convatec INC. | $44.17 | 2023 | |
| Surgenex LLC | $42.12 | 2025 | Renograft, Pellograft, Surmatrix |
| Biotissue Holdings INC. | $39.28 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| In2bones USA, LLC | $38.96 | 2021 | |
| Boston Scientific Corporation | $36.81 | 2024 | Wavewriter Alpha Prime 16 |
| Nabriva Therapeutics, Plc | $34.08 | 2021-2022 | |
| Melinta Therapeutics, LLC | $31.96 | 2024-2025 | Orbactiv, Kimyrsa |
| Integra Lifesciences Corporation | $29.68 | 2019-2023 | Tenoglide |
| Horizon Therapeutics Plc | $25.32 | 2019-2022 | |
| Stryker Corporation | $23.73 | 2020 | |
| Titan Surgical Group, LLC | $19.18 | 2022 | |
| Abbott Laboratories | $18.60 | 2025 | Proclaim |
| Djo, LLC | $18.55 | 2025 | Cmf |
| Zimmer Biomet Holdings, INC. | $15.69 | 2020 | |
| Deroyal Industries, INC. | $14.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.